Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma

被引:0
|
作者
Z. Gordon Jiang
Yan Wu
Eva Csizmadia
Linda Feldbrügge
Keiichi Enjyoji
John Tigges
Vasilis Toxavidis
Holger Stephan
Christina E. Müller
C. James McKnight
Alan Moss
Simon C. Robson
机构
[1] Beth Israel Deaconess Medical Center,Division of Gastroenterology and Hepatology, Department of Medicine
[2] Beth Israel Deaconess Medical Center,Transplant Institute
[3] Beth Israel Deaconess Medical Center,Flow Cytometry Core Facility
[4] Harvard Medical School,Department of Surgery
[5] University Hospital Leipzig,Institute of Radiopharmaceutical Cancer Research
[6] Helmholtz-Zentrum Dresden-Rossendorf,Pharmaceutical Institute, Pharmaceutical Sciences Bonn (PSB)
[7] University of Bonn,Department of Physiology & Biophysics
[8] Boston University School of Medicine,undefined
来源
Purinergic Signalling | 2014年 / 10卷
关键词
Ecto-nucleotidase; CD39; ATP; ADP; Adenosine; Purinergic signaling; TLC;
D O I
暂无
中图分类号
学科分类号
摘要
Phosphohydrolysis of extracellular ATP and ADP is an essential step in purinergic signaling that regulates key pathophysiological processes, such as those linked to inflammation. Classically, this reaction has been known to occur in the pericellular milieu catalyzed by membrane bound cellular ecto-nucleotidases, which can be released in the form of both soluble ecto-enzymes as well as being associated with exosomes. Circulating ecto-nucleoside triphosphate diphosphohydrolase 1 (NTPDase 1/CD39) and adenylate kinase 1 (AK1) activities have been shown to be present in plasma. However, other ecto-nucleotidases have not been characterized in depth. An in vitro ADPase assay was developed to probe the ecto-enzymes responsible for the ecto-nucleotidase activity in human platelet-free plasma, in combination with various specific biochemical inhibitors. Identities of ecto-nucleotidases were further characterized by chromatography, immunoblotting, and flow cytometry of circulating exosomes. We noted that microparticle-bound E-NTPDases and soluble AK1 constitute the highest levels of ecto-nucleotidase activity in human plasma. All four cell membrane expressed E-NTPDases are also found in circulating microparticles in human plasma, inclusive of: CD39, NTPDase 2 (CD39L1), NTPDase 3 (CD39L3), and NTPDase 8. CD39 family members and other ecto-nucleotidases are found on distinct microparticle populations. A significant proportion of the microparticle-associated ecto-nucleotidase activity is sensitive to POM6, inferring the presence of NTPDases, either −2 or/and −3. We have refined ADPase assays of human plasma from healthy volunteers and have found that CD39, NTPDases 2, 3, and 8 to be associated with circulating microparticles, whereas soluble AK1 is present in human plasma. These ecto-enzymes constitute the bulk circulating ADPase activity, suggesting a broader implication of CD39 family and other ecto-enzymes in the regulation of extracellular nucleotide metabolism.
引用
收藏
页码:611 / 618
页数:7
相关论文
共 41 条
  • [21] CD39 is the dominant Langerhans cell associated ecto-NTPDase:: Modulatory roles in inflammation and immune responsiveness
    Mizumoto, N
    Kumamoto, T
    Robson, SC
    Sévigny, J
    Matsue, H
    Enjyoji, K
    Takashima, A
    NATURE MEDICINE, 2002, 8 (04) : 358 - 365
  • [22] CD73 and CD39: immune-inhibitory ecto-enzymes as novel regulators of human hair growth
    Bertolini, M.
    Ponce, L.
    Figlak, K.
    Uchida, Y.
    Cheret, J.
    Waldmann, H.
    Paus, R.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E46 - E46
  • [23] THE FULLY HUMAN ANTIBODY SRF617 IS A POTENT INHIBITOR OF ECTO-ENZYME CD39 IN VIVO
    Matissek, Stephan
    Sicheva, Marisella Panduro
    Koseoglu, Secil
    Masia, Ricard
    Warren, Michael
    Rausch, Matthew
    Lee, Benjamin
    Pommey, Sandra
    Cousineau, Isabelle
    Stagg, John
    Palombella, Vito
    Lake, Andrew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A267 - A267
  • [24] Blockade and reversal of human platelet reactivity by CD39/ecto-ADPase. Potential for antithrombotic therapeusis.
    Marcus, AJ
    Broekman, MJ
    Drosopoulos, JH
    Gayle, RB
    McTaggart, RA
    Pinsky, DJ
    Islam, N
    Buergler, JM
    Ali, MN
    Maliszewski, CR
    BLOOD, 1999, 94 (10) : 368A - 368A
  • [25] A bacterial ecto-triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of Legionella pneumophila
    Sansom, Fiona M.
    Newton, Hayley J.
    Crikis, Sandra
    Cianciotto, Nicholas P.
    Cowan, Peter J.
    d'Apice, Anthony J. F.
    Hartland, Elizabeth L.
    CELLULAR MICROBIOLOGY, 2007, 9 (08) : 1922 - 1935
  • [26] Synthesis and characterization of nucleotide mimetics as inhibitors of ecto-5′-nucleotidase (CD73) and NTPDase1 (CD39)
    Brunschweiger, A.
    Iqbal, J.
    Lee, S. -Y
    Munkonda, M. N.
    Sevigny, J.
    Zimmermann, H.
    Mueller, C. E.
    PURINERGIC SIGNALLING, 2008, 4 : S104 - S104
  • [27] EXPRESSION, DISTRIBUTION, AND BIOCHEMISTRY OF HUMAN CD39 - ROLE IN ACTIVATION-ASSOCIATED HOMOTYPIC ADHESION OF LYMPHOCYTES
    KANSAS, GS
    WOOD, GS
    TEDDER, TF
    JOURNAL OF IMMUNOLOGY, 1991, 146 (07): : 2235 - 2244
  • [28] Characterization of AB598, a therapeutic anti-human CD39 antibody for the treatment of cancer
    Anderson, Amy E.
    Kaplan, Angelo
    Vani, Urvi
    Stagnaro, Enzo
    Parashar, Kaustubh
    Clor, Julie
    Walker, Nigel P.
    Young, Steve W.
    Walters, Matthew J.
    Fernandez-Salas, Ester
    Bowman, Christine E.
    Seitz, Lisa
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Roles of Asp54 and Asp213 in Ca2+ utilization by soluble human CD39/ecto-nucleotidase
    Drosopoulos, JHF
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 406 (01) : 85 - 95
  • [30] CD39 and CD326 Are Bona Fide Markers of Murine and Human Plasma Cells and Identify a Bone Marrow Specific Plasma Cell Subpopulation in Lupus
    Dang, Van Duc
    Mohr, Elodie
    Szelinski, Franziska
    Le, Tuan Anh
    Ritter, Jacob
    Hinnenthal, Timo
    Stefanski, Ana-Luisa
    Schrezenmeier, Eva
    Ocvirk, Soeren
    Hipfl, Christian
    Hardt, Sebastian
    Cheng, Qingyu
    Hiepe, Falk
    Loehning, Max
    Doerner, Thomas
    Lino, Andreia C.
    FRONTIERS IN IMMUNOLOGY, 2022, 13